Nuveen’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-51,600
Closed -$10K – 3395
2021
Q1
$10K Buy
+51,600
New +$10.2M ﹤0.01% 3306
2020
Q2
– Sell
-20,400
Closed -$4K – 3286
2020
Q1
$4K Hold
20,400
– – ﹤0.01% 3159
2019
Q4
$4K Buy
+20,400
New +$4.18M ﹤0.01% 3199

Other funds holding CME

Nuveen's CME Position: Q2 2026 in Review

Nuveen reduced its CME Group (CME) stake by 13% in Q2 2026, selling an estimated $37.5M and leaving 925,982 shares worth $204M. The position accounts for 0.05% of the portfolio, ranked #273.

Nuveen first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $663M in Q3 2019. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nuveen held 925,982 shares of CME Group worth $204M as of Q2 2026.
  • Nuveen sold 135,575 CME Group shares in Q2 2026, an estimated $37.5M.
  • CME Group made up 0.05% of Nuveen's portfolio in Q2 2026, its #273 holding.
  • Nuveen first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's CME Group position peaked at $663M in Q3 2019.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.